In particular, in human melanoma patients, iNKT cells could also reverse the immune-suppressive activity of a population of neutrophils producing IL-10, by inducing their maturation toward IL-12-producing cells via CD1d- and CD40- interactions, ultimately reinstating the activation of tumor antigen-specific CD8+ T cells (84). Here, CD1D is linked to melanoma.